Solithromycin Pediatric Development Program,
Role: Principal Investigator,
Duke University,
(08/2017 - 05/2018)
Status: Closed
For Profit Organization
A phase 2/3 randomized open-label multi-center study to determine the safety and efficacy of solithromycin in adolescents (12 to 17 years of age, inclusive) and children (> 2 months to < 12 years of age) with suspected or confirmed to community-acquired bacterial pneumonia (CABP),
Role: PI,
Cempra Pharmaceuticals,
(05/2017 - 05/2018)
Status: Completed
Internal
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 Infection: An Institutional Experience,
Role: Investigator,
LLU Dept. of Pediatrics,
(03/2021)
Status: Approved
Databank of children and adolescents admitted to LLUCH for treatment of an eating disorder,
Role: PI,
LLU Dept. of Pediatrics,
(05/2020)
Status: Approved
Comparing creatinine in children and adolescents with eating disorders and elite athletes,
Role: PI,
LLU Dept. of Pediatrics,
(03/2020)
Status: Approved